Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Atossa Therapeutics, Inc. - Common Stock
(NQ:
ATOS
)
0.6549
-0.0040 (-0.61%)
Streaming Delayed Price
Updated: 3:42 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atossa Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Analyzing Atossa Therapeutics's Unusual Options Activity
↗
August 04, 2021
Atossa Therapeutics (NASDAQ:ATOS) shares experienced unusu...
Via
Benzinga
Investors Should Avoid High-Risk Atossa Therapeutics
↗
August 02, 2021
Given the early stages of Atossa's clinical trials, ATOS stock is too risky to get involved with at this point.
Via
InvestorPlace
63 Biggest Movers From Friday
↗
August 02, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...
Via
Benzinga
The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs
↗
July 31, 2021
A look at lessons learned from active trading of IPOs, ETFs, Russian Dolls, and a discussion on what might be the secret to trading-which ironically, is the polar opposite to trading.
Via
Talk Markets
ATOS Stock: The Big News That Has Atossa Therapeutics Plunging 20% Today
↗
July 30, 2021
ATOS stock is on its way down today. As the biotech company announces a special shareholder meeting, holders worry about stock dilution.
Via
InvestorPlace
Topics
Intellectual Property
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 30, 2021
Gainers Erytech Pharma (NASDAQ:ERYP) sha...
Via
Benzinga
41 Stocks Moving In Friday's Mid-Day Session
↗
July 30, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares jumped 90.6% to $7.84 after the company said the FDA has granted its eryaspase fast track designation for the treatment of acute...
Via
Benzinga
20 Stocks Moving in Friday's Pre-Market Session
↗
July 30, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 50.9% to $6.20 in pre-market trading after the company announced its eryaspase was granted U.S. FDA Fast Track designation...
Via
Benzinga
Understanding Atossa Therapeutics's Unusual Options Activity
↗
July 29, 2021
Atossa Therapeutics (NASDAQ:ATOS) shares experienced unusual options activity on Thursday. The stock price moved up to $4.08 following the option alert. Sentiment: BEARISH...
Via
Benzinga
Wait for Atossa Therapeutics Stock to Slide Further Before Buying
↗
July 28, 2021
The potential with its breast cancer and Covid-19 treatment candidates notwithstanding, don't fight the trend with ATOS stock.
Via
InvestorPlace
Analyzing Atossa Therapeutics's Unusual Options Activity
↗
July 28, 2021
Shares of Atossa Therapeutics (NASDAQ:ATOS) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $3.89. Sentiment:...
Via
Benzinga
Atossa Therapeutics Might Shoot Up Quickly on Covid-19 Fear
↗
July 28, 2021
ATOS stock has already proven volatile and that shouldn't abate
Via
InvestorPlace
Think Carefully Before Speculating on Atossa Therapeutics
↗
July 27, 2021
While the fundamentals for ATOS stock are intriguing, the counterarguments could be stronger.
Via
InvestorPlace
Analyzing Atossa Therapeutics's Unusual Options Activity
↗
July 21, 2021
On Wednesday, shares of Atossa Therapeutics (NASDAQ:ATOS) saw unusual options activity. After the option alert, the stock price moved up to $4.27. Sentiment: BEARISH Option Type...
Via
Benzinga
54 Biggest Movers From Yesterday
↗
July 20, 2021
Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon...
Via
Benzinga
Is Atossa Therapeutics Stock Breaking Important Support?
↗
July 19, 2021
After a steep selloff, shares of Atossa Therapeutics, Inc. (NASDAQ: ATOS) have reached the critical $4 level. This level was support in early June. It had previously been a...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 19, 2021
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. The company's market cap stands at $684.2...
Via
Benzinga
50 Biggest Movers From Friday
↗
July 19, 2021
Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 41.2% to settle at $7.10 on Friday. Blue Foundry Bancorp (NASDAQ: BLFY) gained 29% to close at $12.90 after the...
Via
Benzinga
The Week In Charts: Learning From Doing Trading “Stuff” All Day
↗
July 16, 2021
A discussion on the fact that markets have been hectic as of late and what can be learned from
Via
Talk Markets
Most Active Equity Options For Midday - Friday, July 16
↗
July 16, 2021
Top tickers for midday: AAPL, TSLA, AMC, AMZN, SNAP, NVDA, NIO, MSFT, MRNA, ATOS, BABA, SPCE, AMD, BAC, FB, BA, CCL, MU, PLTR, DIS.
Via
Talk Markets
33 Stocks Moving In Friday's Mid-Day Session
↗
July 16, 2021
Gainers TD Holdings, Inc. (NASDAQ: GLG) jumped 49% to $1.21 after the company entered a non-binding letter of intent to acquire Guangdong Jinbochuang Special Purpose Vehicle Co....
Via
Benzinga
Understanding Atossa Therapeutics's Unusual Options Activity
↗
July 16, 2021
Shares of Atossa Therapeutics (NASDAQ:ATOS) saw some unusual options activity on Friday. Following the unusual option alert, the stock price moved down to $4.58. Sentiment:...
Via
Benzinga
A Promising Covid-19 Treatment Makes Atossa Therapeutics Intriguing
↗
July 16, 2021
Traders will continue to analyze the short-squeeze potential of ATOS stock, but investors should also focus on Atossa's clinical progress.
Via
InvestorPlace
64 Biggest Movers From Yesterday
↗
July 14, 2021
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday. Red Cat Holdings, Inc. (NASDAQ: RCAT) surged 60.3% to settle at $4.76...
Via
Benzinga
Atossa Therapeutics Stock Runs While Trading In Bearish Pattern
↗
July 13, 2021
Atossa Therapeutics Inc (NASDAQ: ATOS) shares are trading higher Tuesday after retail traders were able to push the stock higher. The stock was trading on above-average...
Via
Benzinga
Most Active Equity Options For Midday - Tuesday, July 13
↗
July 13, 2021
Top tickers for midday: AAPL, TSLA, AMC, NOK, SPCE, MSFT, BABA, AMZN, DIS, BA, BAC, TLRY, NIO, PLTR, SNOW, JPM, SNDL, F, AMD, ATOS.
Via
Talk Markets
Analyzing Atossa Therapeutics's Unusual Options Activity
↗
July 13, 2021
Atossa Therapeutics (NASDAQ:ATOS) shares experienced unusual options activity on Tuesday. The stock price moved up to $5.84 following the option alert. Sentiment: BULLISH Option...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 12, 2021
Gainers SCWorx (NASDAQ:WORX) shares rose...
Via
Benzinga
Unusual Options Activity Insight: Atossa Therapeutics
↗
July 09, 2021
On Friday, shares of Atossa Therapeutics (NASDAQ:ATOS) saw unusual options activity. After the option alert, the stock price moved down to $5.45. Sentiment: BULLISH Option Type...
Via
Benzinga
25 Stocks Moving in Wednesday's Pre-Market Session
↗
July 07, 2021
Gainers Opiant Pharmaceuticals Inc (NASDAQ: OPNT) shares rose 50.9% to $20.00 in pre-market trading after the company disclosed positive top-line results of confirmatory...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.